Executive Summary
Meta Platforms petitions to invalidate SitNet’s ’769 patent covering situational networks, arguing all 30 claims are obvious over prior art. The petition cites multiple earlier patents and publications and seeks cancellation of the entire patent.
Related Cases
Imperative Care, Inc.vsINARI MEDICAL, INC.
The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 B2 embolism‑treatment patent after finding Imperative Care’s obviousness arguments sufficiently persuasive.
Micron Technology, Inc. et al.vsYangtze Memory Technologies Company, Ltd.
The PTAB has instituted an inter partes review of claim 10 of Micron’s challenged 3D NAND patent, finding a reasonable likelihood of unpatentability over the Toyama reference.
Ascentcare Dental Products, Inc.vsSolmetex, LLC
Ascentcare Dental Products has filed an IPR petition challenging Solmetex’s intraoral device patent, asserting that all claims 12‑21 are obvious over prior art. The petition relies on Park, Baughan, Johnson and Hirsch references and seeks cancellation of the claims.
SAVANT TECHNOLOGIES LLC d/b/a GE LIGHTING et al.vsFeit Electric Company, Inc.
Feit Electric seeks Director Review to vacate the institution of two consolidated IPRs covering its LED lighting patent, citing failure to disclose a Chinese parent company and contradictory claim‑construction arguments by the petitioners.
Amphenol CorporationvsCredo Technology Group Ltd.
Amphenol and Credo Technology Group settled four related IPRs before trial, leading the Board to terminate the proceedings and treat the settlement agreement as confidential business information.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.